The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases

被引:284
作者
Cauwe, Benedicte [1 ]
Van den Steen, Philippe E. [1 ]
Opdenakker, Ghislain [1 ]
机构
[1] Univ Leuven, Rega Inst Med Res, Immunol Lab, B-3000 Louvain, Belgium
关键词
ectodomain shedding; receptor; membrane; cancer; immunity; autoimmunity;
D O I
10.1080/10409230701340019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs) constitute a family of more than 20 endopeptidases. Identification of specific matrix and non-matrix components as MMP substrates showed that, aside from their initial role as extracellular matrix modifiers, MMPs play significant roles in highly complex processes such as the regulation of cell behavior, cell-cell communication, and tumor progression. Thanks to the comprehensive examination of the expanded MMP action radius, the initial view of proteases acting in the soluble phase has evolved into a kaleidoscope of proteolytic reactions connected to the cell surface. Important classes of cell surface molecules include adhesion molecules, mediators of apoptosis, receptors, chemokines, cytokines, growth factors, proteases, intercellular junction proteins, and structural molecules. Proteolysis of cell surface proteins by MMPs may have extremely diverse biological implications, ranging from maturation and activation, to inactivation or degradation of substrates. In this way, modification of membrane-associated proteins by MMPs is crucial for communication between cells and the extracellular milieu, and determines cell fate and the integrity of tissues. Hence, insights into the processing of cell surface proteins by MMPs and the concomitant effects on physiological processes as well as on disease onset and evolution, leads the way to innovative therapeutic approaches for cancer, as well as degenerative and inflammatory diseases.
引用
收藏
页码:113 / 185
页数:73
相关论文
共 410 条
  • [21] Hydroxamate-based inhibitors of low affinity IgE receptor (CD23) processing
    Bailey, S
    Bolognese, B
    Buckle, DR
    Faller, A
    Jackson, S
    Louis-Flamberg, P
    McCord, M
    Mayer, RJ
    Marshall, LA
    Smith, DG
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (01) : 23 - 28
  • [22] Metalloproteinase inhibitors: biological actions and therapeutic opportunities
    Baker, AH
    Edwards, DR
    Murphy, G
    [J]. JOURNAL OF CELL SCIENCE, 2002, 115 (19) : 3719 - 3727
  • [23] Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer
    Bandyopadhyay, A
    Wang, L
    Lóepz-Casillas, F
    Mendoza, V
    Yeh, IT
    Sun, LZ
    [J]. PROSTATE, 2005, 63 (01) : 81 - 90
  • [24] Dystroglycan: from biosynthesis to pathogenesis of human disease
    Barresi, R
    Campbell, KP
    [J]. JOURNAL OF CELL SCIENCE, 2006, 119 (02) : 199 - 207
  • [25] MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D
    Basile, John R.
    Holmbeck, Kenn
    Bugge, Thomas H.
    Gutkind, J. Silvio
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (09) : 6899 - 6905
  • [26] Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis
    Basile, John R.
    Castilho, Rogerio M.
    Williams, Vanessa P.
    Gutkind, J. Silvio
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (24) : 9017 - 9022
  • [27] Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B
    Basile, JR
    Barac, A
    Zhu, TQ
    Guan, KL
    Gutkind, JS
    [J]. CANCER RESEARCH, 2004, 64 (15) : 5212 - 5224
  • [28] BAZIL V, 1994, J IMMUNOL, V152, P1314
  • [29] Endothelial tight junctions: permeable barriers of the vessel wall
    Bazzoni, G
    [J]. THROMBOSIS AND HAEMOSTASIS, 2006, 95 (01) : 36 - 42
  • [30] Syndecans in tumor cell adhesion and signaling
    Beauvais D.M.
    Rapraeger A.C.
    [J]. Reproductive Biology and Endocrinology, 2 (1)